Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ivan Bassanini has a total of 168 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chemoenzymatic Synthesis of Chiral Piperidines Using the Immobilized Transaminase ATA‐117 in Continuous Flow Reactors

    by Sara Vicinanza, Ilaria Magrini Alunno, Stefania Patti, Morena Pirotta, Francesca Annunziata, Raffaella Gandolfi, Paola Conti, Chiara Borsari, Ivan Bassanini, Erica Elisa Ferrandi, et al.

    Nowadays, there is a growing need for streamlined and sustainable strategies to access chiral nitrogen heterocycles, whose stereodefined frameworks underpin their broad functional and pharmaceutical relevance. Herein, we report a robust continuous flow enzymatic protocol for the stereoselective synthesis of the natural alkaloid (–)‐pinidinone and demonstrate its applicability to the preparation of a small family of structurally diverse chiral 2,6‐disubstituted piperidines. The strategy relies on the enantioselective transamination of tailor‐made α , β ‐unsaturated ketones catalyzed by an immobilized form of ATA‐117, which triggers a spontaneous intramolecular aza‐Michael reaction, enabling rapid access to chiral cis ‐(2 R ,6 R )‐piperidine scaffolds under mild conditions. The enzyme, successfully immobilized on Eupergit C, showed good operational and storage stability while a dual‐flow feed configuration minimized the formation of imine and Michael‐type by‐products observed when a single stock solution of α , β ‐unsaturated ketone acceptor and isopropylamine (IPA) amino donor was employed. The optimized conditions (20 mM substrate, 200 mM IPA, 60 min residence time, 30 °C) allowed for complete conversion and high stereoselectivity, while an integrated in‐line work‐up improved automation and reduced manual handling. This study establishes a robust biocatalytic flow platform for the asymmetric synthesis of valuable nitrogen‐containing heterocycles.

  • Open Access

    Selective allosteric regulation of Leishmania braziliensis Hsp90 through a parasite-specific regulatory hub

    by Erica E. Ferrandi, Laura O' Byrne, Alessia Vago, Patrizia Rebuffini, Massimiliano Meli, Silvia Parapini, Katiuscia Pagano, Laura Ragona, Anna Sparatore, Elisabetta Moroni, et al.

  • Open Access

    Studies on the enzymatic amination of the biomass derivatives cyrene and levoglucosenone

    by William Mincigrucci, Ilaria Magrini Alunno, Sara Pedroni, Ivan Bassanini, Erica Elisa Ferrandi, Giovanni Fronza, Stefano Gandolfi, Daniela Monti, Sergio Riva

  • Open Access

    Discovery and Characterization of Novel 2-Phosphoglycerate Kinase and Cyclic 2,3-Diphosphoglycerate Synthase from Thermophilic (Meta)Genomes

    by Stefania Patti, Simone A. De Rose, Michail N. Isupov, Ilya V. Kublanov, Ilaria Magrini Alunno, Sergio Riva, Ivan Bassanini, Eleonora Dore, Christina Stracke, Bettina Siebers, et al.

    2-Phosphoglycerate kinase (2PGK) and cyclic 2,3-diphosphoglycerate synthase (cDPGS) are key enzymes involved in the biosynthesis of cyclic 2,3-diphosphoglycerate (cDPG), an extremolyte known to stabilize proteins in hyperthermophilic Archaea. Using bioinformatics approaches, two candidate genes for each enzyme were identified from a range of thermophilic bacterial and archaeal genomes and metagenomes. Significantly, one gene pair derived from the Taman mud volcano metagenome represents the first indication of a bacterial cDPG biosynthesis pathway. The recombinant expression and purification of these enzymes paved the way to their biochemical and structural characterization. One 2PGK candidate displayed predominant ATPase activity, while the newly identified cDPGS variants demonstrated cDPG synthase activity. Moreover, one of the latter biocatalysts, Ts-cDPGS from the hyperthermophilic archaeon Thermococcus sibiricus, demonstrated a notable thermostability and its 3D structure was resolved at a resolution of 2.2 Å. These findings broaden our understanding of extremophilic enzyme systems and lay the foundation for biotechnological applications involving extremolyte production.

  • Open Access

    Affinity-Based Copolymer Coating for Oriented Protein Immobilization in Biosensor Development

    by Lorenzo Zarini, Thomas Carzaniga, Morena Pirotta, Francesco Damin, Dario Brambilla, Marcella Chiari, Ivan Bassanini, Paola Gagni, Alessandro Mussida, Luca Casiraghi, et al.

    Effective protein immobilization is a critical step in biosensor development, as it ensures the stability, functionality, and orientation of biomolecules on the sensor surface. Here, we present a novel affinity-based terpolymer coating designed to enhance protein immobilization for biosensor applications. The novelty lies in the incorporation of nitrilotriacetic acid (NTA) ligands directly into the polymeric chains, facilitating histidine-tagged protein oriented binding through a robust metal-chelating interaction. To validate the system, magnetic microbeads coated with the polymer were tested for their ability to bind native and His-tagged proteins. The results demonstrated the superior binding capacity, enhanced stability, and reversibility of the interactions compared to traditional coatings, which immobilize proteins through nucleophile reactions with amine residues. Moreover, enzyme immobilization tests confirmed that the polymer preserves enzymatic activity, highlighting its potential for biosensor applications requiring functional biomolecules. This innovative polymeric coating offers a fast, versatile, and scalable solution for next-generation biosensor platforms, paving the way for improved sensitivity, reliability, and accessibility in diagnostic and analytical technologies.


  • Open Access

    Unlocking Lactonase Enzymes as Biocatalysts for the Deracemisation of Chiral γ‐Thiolactones

    by Jingyue Wu, Michele Crotti, Ivan Bassanini, Mahdi Hassankalhori, Erica Elisa Ferrandi, Ferran Sancho, Daniela Monti, Daniele Castagnolo

    Lactonases, a class of metalloenzymes that exhibit catalytic promiscuity, have been extensively studied from a biological perspective, yet their application as biocatalysts remains underexplored. In this study, we disclose the biocatalytic activity of lactonase enzymes in the hydrolysis and deracemisation of chiral C3‐substituted‐γ‐thiolactones and the asymmetric synthesis of γ‐thio‐α‐substituted‐carboxylic acids. The thiolactonase activity of lactonases from different protein superfamilies was investigated. The biocatalyst GcL, from the metallo‐β‐lactamase‐like lactonase family, catalysed the enzymatic kinetic resolution (EKR) of homocysteine (Hcy) thiolactones with excellent enantioselectivity ( E ‐value up to 136), yielding enantioenriched Hcy thiolactones and γ‐thio‐α‐amino‐carboxylic acids with high ees. Additionally, the biocatalyst N9 Y71G, a rationally engineered variant of the reconstructed ancestral paraoxonase enzyme N9, catalysed the dynamic kinetic resolution (DKR) of C3‐thio‐γ‐thiolactones, yielding γ‐thio‐α‐thio‐carboxylic acids in enantioselective manner with high ees (up to >99%) and yields (up to >99%). Insights on the mechanism and the stereoselectivity of the lactonase biocatalysts were gained through computational and site‐directed mutagenesis studies.

  • Open Access

    Unlocking Lactonase Enzymes as Biocatalysts for the Deracemisation of Chiral γ‐Thiolactones

    by Jingyue Wu, Michele Crotti, Ivan Bassanini, Mahdi Hassankalhori, Erica Elisa Ferrandi, Ferran Sancho, Daniela Monti, Daniele Castagnolo

    Lactonases, a class of metalloenzymes that exhibit catalytic promiscuity, have been extensively studied from a biological perspective, yet their application as biocatalysts remains underexplored. In this study, we disclose the biocatalytic activity of lactonase enzymes in the hydrolysis and deracemisation of chiral C3‐substituted‐γ‐thiolactones and the asymmetric synthesis of γ‐thio‐α‐substituted‐carboxylic acids. The thiolactonase activity of lactonases from different protein superfamilies was investigated. The biocatalyst GcL, from the metallo‐β‐lactamase‐like lactonase family, catalysed the enzymatic kinetic resolution (EKR) of homocysteine (Hcy) thiolactones with excellent enantioselectivity ( E ‐value up to 136), yielding enantioenriched Hcy thiolactones and γ‐thio‐α‐amino‐carboxylic acids with high ees. Additionally, the biocatalyst N9 Y71G, a rationally engineered variant of the reconstructed ancestral paraoxonase enzyme N9, catalysed the dynamic kinetic resolution (DKR) of C3‐thio‐γ‐thiolactones, yielding γ‐thio‐α‐thio‐carboxylic acids in enantioselective manner with high ees (up to >99%) and yields (up to >99%). Insights on the mechanism and the stereoselectivity of the lactonase biocatalysts were gained through computational and site‐directed mutagenesis studies.


  • Open Access

    In Vitro Screening of an In-House Library of Structurally Distinct Chemotypes Towards the Identification of Novel SARS-CoV-2 Inhibitors

    by Michele Tonelli, Anna Sparatore, Ivan Bassanini, Valeria Francesconi, Fabio Sparatore, Kevin K. Maina, Serena Delbue, Sarah D’alessandro, Silvia Parapini, Nicoletta Basilico

    Background/Objectives: Four years after the COVID-19 pandemic, a very limited number of drugs has been marketed; thus, the search for new medications still represents a compelling need. In our previous work on antiviral, antiparasitic, and antiproliferative agents, we described several compounds (1–13 and 16–20) structurally related to clofazimine, chloroquine, and benzimidazole derivatives. Thus, we deemed it worthwhile to test them against the replication of SARS-CoV-2, together with a few other compounds (14, 15 and 21–25), which showed some analogy to miscellaneous anti-coronavirus agents. Methods: Twenty-five structurally assorted compounds were evaluated in vitro for cytotoxicity against Vero E6 and for their ability to inhibit SARS-CoV-2 replication. Results: Several compounds (2, 3, 10, 11, 13–15, 18–20) demonstrated antiviral activity (IC50 range 1.5–28 µM) and six of them exhibited an interesting selectivity index in the range 4.5–20. The chloroquine analogs 10 and 11 were more potent than the reference chloroquine itself and doubled its SI value (20 versus 11). Also, the benzimidazole ring emerged as a valuable scaffold, originating several compounds (13–15 and 18–20) endowed with anti-SARS-CoV-2 activity. Despite the modest activity, the cytisine and the arylamino enone derivatives 23 and 25, respectively, also deserve further consideration as model compounds. Conclusions: The investigated chemotypes may represent valuable hit compounds, deserving further in-depth biological studies to define their mechanisms of action. The derived information will guide the subsequent chemical optimization towards the development of more efficient anti-SARS-CoV-2 agents.


  • Open Access

    “Novel chemo-enzymatic synthesis, structural elucidation and first antiprotozoal activity profiling of the atropoisomeric dimers of trans-8-Hydroxycalamenene”

    by Ivan Bassanini, Chiara Tognoli, Massimiliano Meli, Silvia Parapini, Nicoletta Basilico, Giovanni Fronza, Stefano Serra, Sergio Riva

  • A ChemoEnzymatic Approach for the Preparation of “Linear‐Shaped” Diaryl Pyrazines as Potential Antiprotozoal Agents

    by Ivan Bassanini, Tommaso Braga, Chiara Tognoli, Marta Vanoni, Gaia Mazza, Nicoletta Basilico, Silvia Parapini, Sergio Riva

    Nitrogenous heterocyclic rings are present in a wide range of drugs, natural compounds, and fine chemicals and are considered privileged scaffolds in medicinal chemistry. Seeking novel anti‐protozoal drugs acting on new targets or by novel mechanisms of action, we focused on a preliminary evaluation of the potential of “linear‐shaped” diaryl pyrazines. To this purpose, a two‐enzyme chemoenzymatic synthesis of this heteroaromatic core was carried out. Specifically, starting from simple, commercially available aromatic aldehydes, the target pyrazines were obtained through a sequence of biocatalytic benzoin condensation, chemical oxidation and a transaminase‐mediated tandem process of transamination and cyclization. The profiles of the compounds as antiprotozoal agents were evaluated in vitro against parasites cultures of the Leishmania and Plasmodium genera and using the human cell line HepG2.